Development of a novel transgenic rat overexpressing the P2Y2 nucleotide receptor using a lentiviral vector

Journal of Vascular Research

Volumn 46, Issue 5, 2009, Pages 447-458

  Agca, Cansu ^a   Seye, Cheikh ^b   Kashuba Benson, Corinna M ^a   Rikka, Shivaji ^b   Chan, Anthony W S ^c   Weisman, Gary A ^b   Agca, Yuksel ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nucleotide; P2Y2 receptor; Sj gren's syndrome, transgenic rat

Indexed keywords

CALCIUM; LENTIVIRUS VECTOR; MESSENGER RNA; PURINERGIC P2Y2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ISOLATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; FEMALE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SJOEGREN SYNDROME; SMOOTH MUSCLE FIBER; TISSUE INJURY; TRANSGENIC RAT;

ANIMALS; ANIMALS, OUTBRED STRAINS; AORTA; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HOMOZYGOTE; LENTIVIRUS; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECEPTORS, PURINERGIC P2; SJOGREN'S SYNDROME; TRANSGENES;

EID: 58249130841     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000194274     Document Type: Article

References (53)

1. Boeynaems JM, Communi D, Gonzalez NS, Robaye B: Overview of the P2 receptors. Semin Thromb Hemost 2005; 31: 139-149.
2. Khakh BS, North RA: P2X receptors as cellsurface ATP sensors in health and disease. Nature 2006; 442: 527-532.
3. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA: International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006; 58: 281-341.
4. Erb L, Liao Z, Seye CI, Weisman GA: P2 receptors: intracellular signaling. Pflugers Arch 2006; 452: 552-562.
5. 2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci USA 2005; 102: 19138-19143.
6. 2 receptor activation: novel pathways for neuronal survival. J Neurosci 2006; 26: 3798-3804.
7. 2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol Neurobiol 2005; 31: 169-183.
8. 2 nucleotide receptors enhance alphasecretase-dependent amyloid precursor protein processing. J Biol Chem 2005; 280: 18696-18702.
9. 2 receptors promote hepatocyte resistance to hypoxia. J Hepatol 2006; 45: 236-245.
10. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG: ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006; 314: 1792-1795.
11. 2 nucleotide receptor mediates UTPinduced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 2003; 278: 24960-24965.
12. Mediero A, Peral A, Pintor J: Dual roles of diadenosine polyphosphates in corneal epithelial cell migration. Invest Ophthalmol Vis Sci 2006; 47: 4500-4506.
13. Greig AV, Linge C, Cambrey A, Burnstock G: Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 2003; 121: 1145-1149.
14. 2 nucleotide receptor expression in the ductligated rat submandibular gland. Am J Physiol Cell Physiol 2000; 279:C286-C294.
15. 2 nucleotide receptor up-regulation in submandibular gland cells from the NOD. B10 mouse model of Sjogren's syndrome. Arch Oral Biol 2005; 50: 533-540.
16. 2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 1997; 17: 3602-3610.
17. 2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 2002; 106: 2720-2726.
18. Godecke S, Decking UK, Godecke A, Schrader J: Cloning of the rat P2u receptor and its potential role in coronary vasodilation. Am J Physiol 1996; 270:C570-C577.
19. Pearson JD, Gordon JL: P2 purinoceptors in the blood vessel wall. Biochem Pharmacol 1989; 38: 4157-4163.
20. Lustig KD, Sportiello MG, Erb L, Weisman GA: A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP. Biochem J 1992; 284: 733-739.
21. 2 receptor in bone remodeling. J Cell Biochem 2002; 86: 413-419.
22. 2 receptors and pyrophosphate. Endocrinology 2007; 148: 4208-4216.
23. 2 and p38 MAPK-dependent pathways. Am J Physiol Lung Cell Mol Physiol 2006; 291:L734-L746.
24. Geary C, Akinbi H, Korfhagen T, Fabre JE, Boucher R, Rice W: Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa . Am J Physiol Lung Cell Mol Physiol 2005; 289: L890-L895.
25. 2+ influx. Pharmacogenet Genomics 2006; 16: 199-205.
26. 2 receptor gene expression on nucleotide regulation of murine epithelial Cl-transport. J Biol Chem 1999; 274: 26461-26468.
27. Tesson L, Cozzi J, Menoret S, Remy S, Usal C, Fraichard A, Anegon I: Transgenic modifications of the rat genome. Transgenic Res 2005; 14: 531-546.
28. Koch AK: Experimental modeling and research methodology; in Suckow MA, Weisbroth SH, Franklin CL (eds): The Laboratory Rats, ed 2. San Diego, Academic Press, 2005, pp 587-625.
29. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D: Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-872.
30. Bryda EC, Pearson M, Agca Y, Bauer BA: Method for detection and identification of multiple chromosomal integration sites in transgenic animals created with lentivirus. Biotechniques 2006; 41: 715-719.
31. Yang H, Agca Y, Cheng P, Yang J, Agca C, Chan AWS: Enhanced transgenesis by intracytoplasmic injection of bald lentivirus. Genesis 2007; 45: 177-183.
32. Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiher H, Angel P: The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 1996; 24: 1787-1788.
33. Armstrong DT, Opavsky MA: Superovulation of immature rats by continuous infusion of follicle-stimulating hormone. Biol Reprod 1988; 39: 511-518.
34. Bavister BD, Leibfred ML, Lieberman G: Development of preimplantation embryos of the golden hamster in a defined medium. Biol Reprod 1983; 28: 235-247.
35. Pfaff RT, Agca Y, Liu J, Woods EJ, Peter AT, Critser JK: Cryobiology of rat embryos I: determination of zygote membrane permeability coefficients for water and cryoprotectants, their activation energies, and the development of improved cryopreservation methods. Biol Reprod 2000; 63: 1294-1302.
36. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH: Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 1980; 77: 7380-7384.
37. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344: 541-544.
38. Agca Y, Critser JK: Assisted reproductive technologies and genetic engineering in rats; in Suckow MA, Weisbroth SH, Franklin CL (eds): The Laboratory Rats, ed 2. San Diego, Academic Press, 2005, pp 165-190.
39. Charreau B, Tesson L, Soulillou JP, Pourcel C, Anegon I: Transgenesis in rats: technical aspects and models. Transgenic Res 1996; 5: 223-234.
40. Mullins LJ, Brooker G, Mullins JJ: Transgenesis in the rat. Methods Mol Biol 2002; 180: 255-270.
41. Jaenisch R, Harbers K, Jahner D, Stewart C, Stuhlmann H: DNA methylation, retroviruses, and embryogenesis. J Cell Biochem 1982; 20: 331-336.
42. Chan AWS, Homan EJ, Ballou LU, Burns JC, Bremel DR: Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc Natl Acad Sci USA 1998; 95: 14028-14033.
43. Pfeifer A, Ikawa M, Dayn Y, Verma IM: Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA 2002; 99: 2140-2145.
44. Hamra FK, Gatlin J, Chapman KM, Grellhesl DM, Garcia JV, Hammer RE, Garbers DL: Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc Natl Acad Sci USA 2002; 199: 14931-14936.
45. Popova E, Bader M, Krivokharchenko A: Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production. Transgenic Res 2005; 14: 729-738.
46. Masaki Y, Sugai S: Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev 2004; 3: 175-182.
47. Johnson S, Hulton SA, Brundler MA, Moss C, Huissoon A, Taylor CM: End-stage renal failure in adolescence with Sjögren's syndrome autoantibodies SSA and SSB. Pediatr Nephrol 2007; 22: 1793-1797.
48. Iwanaga N, Kamachi M, Fujikawa K, Aramaki T, Izumi Y, Arima K, Tamai M, Aratake K, Nakamura H, Origuchi T, Ida H, Kawakami A, Taguchi T, Eguchi K: Membranous glomerulonephritis and non-Hodgkin's lymphoma in a patient with primary Sjögren's syndrome. Intern Med 2007; 46: 191-194.
49. Hard GC, Khan KN: A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol Pathol 2004; 32: 171-180.
50. Katsifis GE, Moutsopoulos NM, Wahl SM: T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 2007; 32: 252-264.
51. Vaudo G, Bocci EB, Shoenfeld Y, Schillaci G, Wu R, Del Papa N, Vitali C, Delle Monache F, Marchesi S, Mannarino E, Gerli R: Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum 2005; 52: 3890-3897.
52. 2 receptor agonists as a treatment for patients with cystic fibrosis lung disease. Adv Drug Deliv Rev 2002; 54: 1463-1474.
53. 2 nucleotide receptor up-regulation in submandibular gland cells from the NOD. B10 mouse model of Sjögren's syndrome. Arch Oral Biol 2005; 50: 533-540.